Clinical Trial Update: Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants [Phase 2]

View source ↗

Summary

This clinical trial update reports that a Phase 2 study of artesunate ointment is investigating its use for treating anal HSIL in HIV-negative participants and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal High-grade Squamous Intraepithelial Lesion
• Anal Hpv Infection
• Anal Intraepithelial Neoplasia

Drugs mentioned

• Artesunate ointment (Artesunate)

Snippet

Sponsor: Frantz Viral Therapeutics, LLC | Conditions: Anal High-grade Squamous Intraepithelial Lesion, Anal HSIL | Phase 2 | Status: RECRUITING